“immunosuppressant drugs”的搜索结果，显示 861-870 项，共有 9805 项

1. 神经科- 临床试验- 妙佑医疗国际

   The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as measured by 6-month PFS rate, ...

2. 外科 - 临床试验- 妙佑医疗国际

   The purpose of this study is to demonstrate 1) feasibility of digital biomarker assessment using wearable in children with solid tumors who undergo surgery ...

3. 神经科- 临床试验- 妙佑医疗国际

   The primary purpose of this study is to create a Mayo Clinic repository for neurodegenerative disorders such as Parkinson's disease (PD), ...

4. 血液科- 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate the safety and tolerability, identify dose-limiting toxicities (DLT) and the maximum tolerated dose (MTD and ...

5. 精神病与心理科- 临床试验- 妙佑医疗国际

   The purpose of this study is to develop and pilot test a culturally relevant, Facebook delivered intervention to promote smoking treatment uptake and ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to learn if the study drug, [225Ac]Ac-PSMA-R2, is safe and tolerable, and has anti-tumor activity in treated patients. Study Of ...

7. 外科 - 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to follow Mayo Clinic patients with severe brachial plexus injuries who underwent upper limb amputation. A Study ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of ths study is to find out more about the side effects of two new drug combinations for lymphoma, TTI-621 and pembrolizumab and TTI-622 and ...

9. 脑肿瘤项目- 临床试验- 妙佑医疗国际

   The purpose of this study is to help generate a repository of Cerebrospinal Fluid (CSF) samples relevant to neuro-oncology research that may facilitate the ...

10. 新闻 - 检验医学与病理学- 妙佑医疗国际

    Advancing medicine one lab test at a time March 26, 2025, 04:00 p.m. CDT · Mayo Clinic Laboratories and Amprion announce collaboration to advance ...